X-18625216-G-A

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2

This summary comes from the ClinGen Evidence Repository: The p.Arg822His variant in CDKL5 is present in 3 XX and 1 XY individuals in gnomAD v3.1.2 (0.0076%) (not sufficient to meet BS1 criteria). Computational analysis prediction tools suggest that the p.Arg822His variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Arg822His variant is observed in at least 2 unaffected individuals (internal database-GeneDX) (BS2). In summary, the p.Arg822His variant in CDKL5 is classified as Likely Benign based on the ACMG/AMP criteria (BS2, BP4). LINK:https://erepo.genome.network/evrepo/ui/classification/CA10360541/MONDO:0100039/016

Frequency

Genomes: 𝑓 0.000037 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000013 ( 0 hom. 8 hem. )

Consequence

CDKL5
NM_001323289.2 missense

Scores

1
3
13

Clinical Significance

Likely benign reviewed by expert panel U:3B:4

Conservation

PhyloP100: 4.83
Variant links:
Genes affected
CDKL5 (HGNC:11411): (cyclin dependent kinase like 5) This gene is a member of Ser/Thr protein kinase family and encodes a phosphorylated protein with protein kinase activity. Mutations in this gene have been associated with X-linked infantile spasm syndrome (ISSX), also known as X-linked West syndrome, and Rett syndrome (RTT). Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CDKL5NM_001323289.2 linkuse as main transcriptc.2465G>A p.Arg822His missense_variant 17/18 ENST00000623535.2 NP_001310218.1 O76039-2
CDKL5NM_001037343.2 linkuse as main transcriptc.2465G>A p.Arg822His missense_variant 18/22 NP_001032420.1 O76039-1
CDKL5NM_003159.3 linkuse as main transcriptc.2465G>A p.Arg822His missense_variant 17/21 NP_003150.1 O76039-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CDKL5ENST00000623535.2 linkuse as main transcriptc.2465G>A p.Arg822His missense_variant 17/181 NM_001323289.2 ENSP00000485244.1 O76039-2

Frequencies

GnomAD3 genomes
AF:
0.0000366
AC:
4
AN:
109345
Hom.:
0
Cov.:
22
AF XY:
0.0000316
AC XY:
1
AN XY:
31649
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000761
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000548
AC:
1
AN:
182596
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
67176
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000122
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000128
AC:
14
AN:
1095860
Hom.:
0
Cov.:
30
AF XY:
0.0000221
AC XY:
8
AN XY:
361488
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000167
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000366
AC:
4
AN:
109345
Hom.:
0
Cov.:
22
AF XY:
0.0000316
AC XY:
1
AN XY:
31649
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000761
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000142
Hom.:
1
Bravo
AF:
0.0000416
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000297
AC:
2
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Uncertain:3Benign:4
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 07, 2021See Variant Classification Assertion Criteria. -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsNov 30, 2016- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoMar 04, 2016- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 30, 2019The p.R822H variant (also known as c.2465G>A), located in coding exon 16 of the CDKL5 gene, results from a G to A substitution at nucleotide position 2465. The arginine at codon 822 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
CDKL5 disorder Benign:1
Likely benign, reviewed by expert panelcurationClinGen Rett and Angelman-like Disorders Variant Curation Expert PanelFeb 20, 2023The p.Arg822His variant in CDKL5 is present in 3 XX and 1 XY individuals in gnomAD v3.1.2 (0.0076%) (not sufficient to meet BS1 criteria). Computational analysis prediction tools suggest that the p.Arg822His variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). The p.Arg822His variant is observed in at least 2 unaffected individuals (internal database-GeneDX) (BS2). In summary, the p.Arg822His variant in CDKL5 is classified as Likely Benign based on the ACMG/AMP criteria (BS2, BP4). -
CDKL5-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 02, 2023This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Developmental and epileptic encephalopathy, 2;CN128785:Angelman syndrome-like Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 06, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.032
T;T;T;.
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.90
.;D;D;D
M_CAP
Pathogenic
0.52
D
MetaRNN
Benign
0.20
T;T;T;T
MetaSVM
Benign
-0.77
T
MutationAssessor
Benign
0.26
N;.;N;N
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.30
N;.;N;.
REVEL
Benign
0.12
Sift
Benign
0.17
T;.;T;.
Sift4G
Benign
0.16
T;.;T;T
Polyphen
0.066
B;.;B;.
Vest4
0.13
MVP
0.66
MPC
0.43
ClinPred
0.23
T
GERP RS
6.0
Varity_R
0.090
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs376429571; hg19: chrX-18643336; COSMIC: COSV101184422; API